Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
about
PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificityDeveloping dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxideS-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolaseGene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscleComparative gene expression analysis by differential clustering approach: application to the Candida albicans transcription programAsymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosisEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressThe role of the intestinal microcirculation in necrotizing enterocolitisPacked red blood cells are an abundant and proximate potential source of nitric oxide synthase inhibitionFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationZn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylationIncreased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferasesStructural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1.Acute effects of Helicobacter pylori extracts on gastric mucosal blood flow in the mouse.Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.Testing for endothelial dysfunction.Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathHelicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.Effects of asymmetric dimethylarginine on bovine retinal capillary endothelial cell proliferation, reactive oxygen species production, permeability, intercellular adhesion molecule-1, and occludin expression.Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.An update on uremic toxins.Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.The Role of Obesity in Preeclampsia.Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Nitric oxide: therapeutic opportunities.Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injuryNitrate tolerance and the links with endothelial dysfunction and oxidative stress.Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age.Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplastyUraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyAsymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension.Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids.Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged RatsThe effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients.Arginine de novo and nitric oxide production in disease states.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.
P2860
Q24320263-64F28E2F-32F9-43B6-814D-049B86860B45Q24321779-8A4A037C-C39E-4023-9996-434FEBD0E1C2Q24536087-61EA4C65-B042-410E-8FBA-E2AE6A17508AQ24538577-E482504D-7156-4D2B-911D-76C3569272FEQ24810484-1AF73BEA-C9D8-4FFF-BBD3-EB8F5EE2FC30Q26795604-4797A3AE-B23B-4065-BC73-C4AFD7B7EE42Q27023122-17566D51-7176-4ECA-8896-B0CA73EE720AQ27691434-DC9BDCF3-1D5F-4D6A-9347-AFE21F93D2B0Q28544807-EBB2ABB5-8F10-4B00-BE36-4BEB20374061Q28581627-07898E16-7970-4F6A-910B-76D3899C1637Q28590295-AE04CBD5-0196-421C-8B25-A4A397EDBA14Q28594903-9F8461A9-348D-4FDC-A572-10A5F03BEEBDQ30328626-DA9380DE-82C0-420C-A2AD-9DD49BBF0C18Q33398616-B21D8B2A-56DC-41CB-9752-EB0A7547B420Q33589158-C6B5DA9B-0B75-4664-A6BF-69BF9327F838Q34008359-1CAFAB7D-1FAB-41CC-86BA-090694122AD7Q34111548-57D7BDEC-F5E1-42F0-B704-3A8A5CD19A8AQ34442956-28BB975A-E1C9-437E-90CC-AE1E63DFADAAQ34550813-A19133E9-C99C-4DB9-BEF1-7FF278250EE4Q34583579-B2C4C765-8451-44BE-B5EB-2FB005B7116EQ34632841-DF9AC11C-BBE8-49BF-BDBE-4722CBEC0524Q34641464-68FB570A-4A32-4244-854F-B7B1B45396AAQ34670457-A7CCAA90-675F-4367-A3E6-2F3894D5B362Q34853745-CD31B824-D0DF-4189-A6B5-FFE26A0D2A3CQ35044177-03C016FE-895D-4772-83D7-A5CAD450EA62Q35055194-F570AD87-B076-4451-A573-95F41542FF18Q35067175-B493165B-0887-404B-88B6-7BCBBAD08251Q35129159-0C46D7C8-962D-4530-A02D-72FEC79AF294Q35583191-6DD1BE89-544E-49C7-B3EE-D17A26D1F0AAQ35595929-266A8077-D436-4CB6-9177-50F2CC620C2EQ35625951-FF7329EB-47F1-463B-BADB-44BF7CDC8761Q35641983-6B8C40E1-8C81-4BC9-ABF6-568DC94E365AQ35674171-F74EDAB0-2EDF-43D7-8474-E3CB09C4FA4DQ35891553-E6637559-C521-4423-B065-2F98A6EED18AQ36025598-C5467A56-8F77-4A50-B02B-1492D0A62A1DQ36203539-3424195C-6C10-4045-866D-1D1451248E23Q36253972-D0EAF504-914D-49D8-849D-B216C83C8A86Q36347868-D7D24D9D-FB13-4323-B20B-9077D675FF32Q36454194-B15405F6-0DDF-4A69-B21D-571EF7AF3BFFQ36471209-85888C5C-8A14-4AA3-93E1-F796D81ABABC
P2860
Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Biological significance of end ...... nhibit nitric oxide synthases.
@ast
Biological significance of end ...... nhibit nitric oxide synthases.
@en
type
label
Biological significance of end ...... nhibit nitric oxide synthases.
@ast
Biological significance of end ...... nhibit nitric oxide synthases.
@en
prefLabel
Biological significance of end ...... nhibit nitric oxide synthases.
@ast
Biological significance of end ...... nhibit nitric oxide synthases.
@en
P1476
Biological significance of end ...... nhibit nitric oxide synthases.
@en
P2093
P304
P356
10.1016/S0008-6363(99)00162-5
P577
1999-08-01T00:00:00Z